Skip to main content
Caplight Logo









30 Technology

30 Technology

Private
LondonHealthcare & Life Scienceshttps://30.technology/

Last Round

VC Round

Nov 16, 2018

Total Funding Raised

$2.32M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

30 Technology is a biopharmaceutical company developing nitric oxide-generating technologies for healthcare applications to combat anti-microbial resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

nitric oxide therapyantimicrobial resistancerespiratory therapeuticsbiopharmaceutical R&Dinhaled antimicrobialdrug delivery platformantibiotic alternativesbiotech licensingcystic fibrosis treatmentbronchiectasis treatmentsuperbug treatmenttherapeutic pipelinemedical device technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

30 Technology Comparables

Compare 30 Technology with similar companies based on industry and business-model similarity.

30 Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Know Bio
79%
Beyond Air
65%
Keenova Therapeutics
63%

30 Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 16, 2018
GrantMay 15, 2017
GrantSep 1, 2013
SeedApr 18, 2012

30 Technology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 4, representing 21% of headcount.

  • Mar 2, 2026

    Monthly visitors increased 85% MoM.

30 Technology Filings

Explore SEC and related filing metadata, where available.

30 Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 30 Technology's valuation, stock price, and market status.

Is 30 Technology a public or private company?

30 Technology is a private company.

What is the current stock price of 30 Technology?

30 Technology is a private company with no public stock price. No recent secondary market data is available.

How much is 30 Technology worth (valuation)?

Valuation information for 30 Technology is not publicly available.

Can I buy 30 Technology stock?

30 Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 30 Technology's last funding round?

30 Technology's most recent funding round was VC Round on November 16, 2018.

Who are the main investors in 30 Technology?

Key investors in 30 Technology include SBRI Healthcare, Morningside Ventures, Medical Research Council.

Will 30 Technology IPO soon?

No public IPO plans have been announced for 30 Technology.

How can I track 30 Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 30 Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2018
Last FundingNov 16, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?